Home › Medicines › Livocard
বাংলায় দেখুন
💊

Livocard

Tablet

🧬 Clopidogrel Bisulphate 🏢 The White Horse Pharmaceuticals Ltd.
Generic Name Clopidogrel Bisulphate
Manufacturer The White Horse Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00) Strip Price: ৳ 120.00

🔹 Indications

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Pharmacology

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Dosage & Administration

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Interaction

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Contraindications

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Side Effects

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Pregnancy & Lactation

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Precautions & Warnings

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Pediatric Usage

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔹 Storage Conditions

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI).

Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke Livocard tablet is indicated to reduce the rate of MI and stroke.

🔍 People also search for

Livocard Livocard Tablet used for Livocard side effects Livocard price Livocard dose Livocard Tablet uses Is Livocard safe Livocard dosage Livocard alternative Livocard Bangladesh Clopidogrel Bisulphate Clopidogrel Bisulphate price Bangladesh Tablet price Bangladesh The White Horse Pharmaceuticals Ltd. medicine bd

💡 Frequently Asked Questions

Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indica...
Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indica...
Acute Coronary Syndrome (ACS): Livocard tablet is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indica...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Anclog Tablet

Square Pharmaceuticals PLC

Unit Price: ৳ 12.03 (4 x 10: ৳ 481.20) Strip Price: ৳ 120.30

Anlet Tablet

Globe Pharmaceuticals Ltd.

Unit Price: ৳ 11.00 (3 x 10: ৳ 330.00) Strip Price: ৳ 110.00

Antiplet Tablet

Rangs Pharmaceuticals Ltd.

Unit Price: ৳ 10.03 (30's pack: ৳ 300.90)

APT Tablet

Sharif Pharmaceuticals Ltd.

Unit Price: ৳ 10.03 (2 x 10: ৳ 200.60) Strip Price: ৳ 100.30

Clognil Tablet

Orion Pharma Ltd.

Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00) Strip Price: ৳ 120.00

Clogrel Tablet

Ad-din Pharmaceuticals Ltd.

Unit Price: ৳ 12.00 (3 x 15: ৳ 540.00) Strip Price: ৳ 180.00

Clont Tablet

Opsonin Pharma Ltd.

Unit Price: ৳ 12.03 (2 x 21: ৳ 505.26) Strip Price: ৳ 252.63

Clopid Tablet

Drug International Ltd.

Unit Price: ৳ 12.05 (2 x 14: ৳ 337.40) Strip Price: ৳ 168.70

Clopilet Tablet

Sun Pharmaceutical (Bangladesh) Ltd.

Unit Price: ৳ 12.00 (5 x 10: ৳ 600.00) Strip Price: ৳ 120.00

Clopirel Tablet

Novo Healthcare and Pharma Ltd.

Unit Price: ৳ 10.00 (30's pack: ৳ 300.00)